FDA Inspections Conclude at Zydus and Aurobindo Plants

The US FDA checked two Indian pharmaceutical plants, one from Zydus and another from Aurobindo, to make sure they are following rules.

Both inspections happened at the same time.

Zydus's plant had four things they needed to fix, and Aurobindo's had eight.

These weren't serious problems.

Both companies will work with the FDA to address the issues.

Zydus also recently launched a new flu vaccine, and their subsidiary signed a deal for a new medicine in the US market.